← Leaderboards
Debra R Counts
University Of Maryland Baltimore
$295,220
Attributed
$295,220
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $166.8K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$295,220 · 15
By mechanism
R21$148,500 · 1
M01$146,720 · 14
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Alessio Fasano$18,889,816
- Deanna L Kelly$13,077,948
- Natalie D Eddington$3,258,783
- Richard Blair Thompson$6,880,147
- Rose Marie Viscardi$8,090,191
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingSourceUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseResourcesInstitutionGrantResearch PersonnelInsulinDiabetes MellitusDiabetes Mellitus, Insulin-DependentClinical ResearchPancreasDiabetes PreventionInsulin-Dependent Diabetes MellitusNewly DiagnosedBloodRelative (Related Person)BaseProductionSamplingCellsChildClinical Trials
Grant awards (17)
EDIC - EPIDEMIOLOGY OF DIABETES INTERVENTIONS & COMPLICATIONS$33,262
M01 · FY2009 · RR · contact PI
TRIALNET$10,504
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: NEW ONSET OF TYPE 1 DIABETES ANTI-CD20 CLINICAL TRIAL$874
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ORAL INSULIN FOR PREVENTION OF DIABETES IN PATIENTS AT RISK FOR$874
M01 · FY2009 · RR · contact PI
TRIALNET$10,071
M01 · FY2008 · RR · contact PI
RCT OF THE EFFECT OF GLUTEN-FREE DIET ON BETA-CELL SURVIVAL$503
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: RITUXIMAB IN NEW ONSET DIABETES$503
M01 · FY2008 · RR · contact PI
TRIALNET$2,455
M01 · FY2007 · RR · contact PI
RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF GLUTEN-FREE DIET ON BETA-CELL SURV$2,455
M01 · FY2007 · RR · contact PI
ZAAT1D-STUDY OF ZONULIN AND ANTI-ZONULIN ANTIBODIES IN PATIENTS WITH TYPE 1 DIA$2,104
M01 · FY2007 · RR · contact PI
Zonulin and cytokines as markers of autoimmunity in Type 1 diabetes$148,500
R21 · FY2006 · DK · contact PI
ZONULIN AND DIABETES$13,863
M01 · FY2006 · RR · contact PI
GLUTEN-FREE DIET AND DIABETES$4,456
M01 · FY2006 · RR · contact PI
ZONULIN AND DIABETES$34,282
M01 · FY2005 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTIONS &COMPLICATIONS$20,316
M01 · FY2005 · RR
Zonulin Antibodies in Intestinal Permeabilitiy in IDDM$7,198
M01 · FY2004 · RR
EDIC$3,000
M01 · FY2004 · RR